Genvor Incorporated
GNVR
$0.2777
-$0.7223-72.23%
| Weiss Ratings | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E- | |||
| Rating Factors | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -92.07% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -97.23% | |||
| 52-Week Low % Change | 32.24% | |||
| Price | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.01 | |||
| 52-Week Low Price | $0.21 | |||
| 52-Week Low Price (Date) | Sep 12, 2024 | |||
| 52-Week High Price (Date) | Aug 09, 2024 | |||
| Valuation | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.61M | |||
| Enterprise Value | 6.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.18 | |||
| Earnings Per Share Growth | 258.63% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -5.06 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.28 | |||
| Enterprise Value/EBITDA (TTM) | -2.02 | |||
| Enterprise Value/EBIT | -2.02 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.67M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 984 261 7338 | |||
| Address | 201 S. Elliott Road Chapel Hill, NC 27514 | |||
| Website | www.genvor.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -5,984.96% | |||
| Return on Equity | -- | |||
| Income Statement | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -3.22M | |||
| EBIT (TTM) | -3.22M | |||
| Net Income (TTM) | -3.43M | |||
| Net Income Avl. to Common (TTM) | -3.43M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -249.05% | |||
| EPS Diluted (TTM) | -0.18 | |||
| EPS Diluted Growth (Q YOY) | -227.50% | |||
| Balance Sheet | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 18.90K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -1.10M | |||
| Current Ratio (Q) | 0.017 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 33.70K | |||
| Total Current Liabilities (Q) | 1.13M | |||
| Total Debt (Q) | 915.80K | |||
| Total Liabilities (Q) | 1.13M | |||
| Total Common Equity (Q) | -1.10M | |||
| Cash Flow | GNVR - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 1.23M | |||
| Net Change in Cash (TTM) | 7.50K | |||
| Levered Free Cash Flow (TTM) | 103.60K | |||
| Cash from Operations (TTM) | -1.23M | |||
